Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Vaccination in Patients With Inflammatory Rheumatic Diseases. The Impact of Anti-rheumatic Treatments on the Immunogenicity of Herpes-zoster Vaccine (Shingrix) and Protection Against Infection (HZ-REUMA)

NCT06763783 is registered in ClinicalTrials.gov with Region Skane as lead sponsor.

NCT NCT06763783
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06763783 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Vaccination in Patients With Inflammatory Rheumatic Diseases. The Impact of Anti-rheumatic Treatments on the Immunogenicity of Herpes-zoster Vaccine (Shingrix) and Protection Against Infection (HZ-REUMA)
Lead sponsor
Region Skane
Phase
Phase 4
Overall status
Enrolling by invitation
Start date
December 17, 2024
Completion date
June 30, 2034
Enrollment
240 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

giant cell arteritis (gca), juvenile chronic arthritis, polyarthritis, polymyalgia rheumatica (pmr), psoriatic arthritis, scleroderma, sle, spondylarthropathies, systemic vasculitis